Current Evidence, Tools, and Resources to Optimize Outcomes for Patients With Renal Cell Carcinoma

Improve your ability to provide individualized, evidence-based treatment of renal cell carcinoma through a CME/CE/CPE-certified text module, an Interactive Decision Support Tool with case-specific recommendations, and expert commentaries.

Share

Program Content

Activities

RCC Outcomes Optimization
Optimizing Outcomes for Patients With RCC
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: April 07, 2023

Expires: April 06, 2024

Activities

RCC Treatment Support Tool
Treatment Decision Support Tool Enhances Therapy Considerations for Metastatic Clear Cell RCC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 10, 2023

Faculty

cover img faculity

Katy Beckermann, MD, PhD

Assistant Professor of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

cover img faculity

Wenxin Xu, MD

Instructor of Medicine
Lank Center for Genitourinary Oncology
Physician
Medical Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from AVEO Pharmaceuticals, Inc.; Bristol Myers Squibb; and Exelixis, Inc.

AVEO Pharmaceuticals, Inc.

Bristol Myers Squibb

Exelixis, Inc.